A New Era of Targeted Therapies for Dogs





Partnering to Advance Canine Cancer Care with Precision Medicine

Cancer is one of the leading causes of death in dogs, and traditional treatment options are often limited. By combining cutting-edge genetic testing with precisely targeted medications, veterinarians now have the tools to offer more personalized and potentially more effective therapies. Stokes Pharmacy is committed to advancing veterinary oncology and supporting veterinarians in delivering compassionate, evidence-based cancer care.

Veterinarians: Using a genomic tumor-profiling test?

Stokes has the largest selection of targeted therapies available

New lower pricing on targeted therapies!

  • Alpelisib
  • Crizotinib
  • Dabrafenib
  • Dasatinib
  • Ibrutinib
  • Imatinib
  • Lapatinib
  • Olaparib
  • Palbociclib
  • Sirolimus
  • Sorafenib
  • Sotorasib
  • Toceranib
  • Trametinib
  • Vemurafenib
  • Vorinostat

Looking for a genomic tumor-profiling provider?

Stokes Pharmacy and Anivive Lifesciences have formed a strategic alliance to bring precision medicine to veterinary oncology—combining SearchLight DNA™ genetic testing with Stokes’ trusted compounding to help you diagnose, treat and fight canine cancer with confidence.

For over 50 years, Stokes Pharmacy has been serving the veterinary community. Our commitment to excellence makes us a natural partner for Anivive in advancing cancer care for dogs.